Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06576973
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-25
Brief Title:
Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma
Sponsor:
Organization:
None